Arelis Agosto, director of Product Research at Global X ETFs, discusses current trends in ETFs like AI and infrastructure ...

Wellness stocks are thriving as Gen Z and millennials prioritize fitness and recovery. Bank of America card data shows ...

The Lundin family’s long-term presence ensures alignment with shareholder interests, and the company has a proven track ...

WestPark Capital initiated coverage on Alphabet with a Buy rating and $210 price target. Despite missing Q4 estimates, ...

The general mood among these heavyweight investors is divided, with 58% leaning bullish and 33% bearish. Among these notable ...

Dogecoin's (CRYPTO: DOGE) recent downturn appears to have attracted big buyers, as whale accumulation surged and traders ...

Apellis' Empaveli receives FDA Priority Review for rare kidney diseases C3G and IC-MPGN. Phase 3 data show strong efficacy in proteinuria reduction.